Dranoff, Glenn
Dana-Farber Cancer Institute,
United States
2025 Rank: 11627
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 421 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 11627 | 12406 |
| Total Cites | 27145 | 29645 |
| H-index | 72 | 79 |
| Hm-index | 24 | 25 |
| Number of Single Authored Papers | 21 | 21 |
| Total Cites to Single Authored Papers | 819 | 833 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 4049 | 4298 |
| Number of Single+First+Last Authored Papers | 76 | 76 |
| Total Cites to Single+First+Last Authored Papers | 13734 | 14612 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 22689 | 24004 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.24 |
| Self-Citation Percentage |
8.43%
|
|
Dranoff, Glenn
Novartis Biomedical Research,
United States
2024 Rank: 11288
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 424 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 11288 | 12092 |
| Total Cites | 24904 | 27332 |
| H-index | 71 | 77 |
| Hm-index | 24 | 25 |
| Number of Single Authored Papers | 21 | 21 |
| Total Cites to Single Authored Papers | 785 | 800 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 3920 | 4198 |
| Number of Single+First+Last Authored Papers | 77 | 77 |
| Total Cites to Single+First+Last Authored Papers | 12997 | 13891 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 20729 | 22017 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.24 |
| Self-Citation Percentage |
8.88%
|
|
Dranoff, Glenn
Novartis Institutes for BioMedical Research, Inc.,
United States
2023 Rank: 10440
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 396 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 10440 | 11301 |
| Total Cites | 23721 | 26152 |
| H-index | 71 | 75 |
| Hm-index | 24 | 24 |
| Number of Single Authored Papers | 21 | 21 |
| Total Cites to Single Authored Papers | 759 | 774 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 3972 | 4257 |
| Number of Single+First+Last Authored Papers | 78 | 78 |
| Total Cites to Single+First+Last Authored Papers | 12493 | 13380 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 19585 | 20856 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.25 |
| Self-Citation Percentage |
9.30%
|
|
Dranoff, Glenn
Novartis Institutes for BioMedical Research, Inc.,
United States
2022 Rank: 10315
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 400 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 10315 | 11036 |
| Total Cites | 22067 | 24387 |
| H-index | 68 | 73 |
| Hm-index | 22 | 23 |
| Number of Single Authored Papers | 21 | 21 |
| Total Cites to Single Authored Papers | 722 | 736 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 3861 | 4144 |
| Number of Single+First+Last Authored Papers | 77 | 77 |
| Total Cites to Single+First+Last Authored Papers | 11712 | 12572 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 18109 | 19314 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.26 |
| Self-Citation Percentage |
9.51%
|
|
Dranoff, Glenn
Novartis Institutes for BioMedical Research, Inc.,
United States
2021 Rank: 9924
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 384 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 9924 | 10627 |
| Total Cites | 21216 | 23518 |
| H-index | 67 | 72 |
| Hm-index | 22 | 23 |
| Number of Single Authored Papers | 21 | 21 |
| Total Cites to Single Authored Papers | 711 | 726 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 3745 | 4028 |
| Number of Single+First+Last Authored Papers | 78 | 78 |
| Total Cites to Single+First+Last Authored Papers | 11309 | 12169 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 17361 | 18545 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.27 |
| Self-Citation Percentage |
9.79%
|
|
Dranoff, Glenn
Novartis Institutes for BioMedical Research, Inc.,
United States
2020 Rank: 9380
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 356 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 9380 | 10082 |
| Total Cites | 19347 | 21591 |
| H-index | 65 | 70 |
| Hm-index | 22 | 23 |
| Number of Single Authored Papers | 21 | 21 |
| Total Cites to Single Authored Papers | 658 | 673 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 3599 | 3882 |
| Number of Single+First+Last Authored Papers | 78 | 78 |
| Total Cites to Single+First+Last Authored Papers | 10333 | 11188 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 15712 | 16852 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.28 |
| Self-Citation Percentage |
10.39%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.